Wilkins MR - Search Results

1

Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical Outcome.

Rhodes CJ, Otero-Núñez P, Wharton J, Swietlik EM, Kariotis S, Harbaum L, Dunning MJ, Elinoff JM, Errington N, Thompson AAR, Iremonger J, Coghlan JG, Corris PA, Howard LS, Kiely DG, Church C, Pepke-Zaba J, Toshner M, Wort SJ, Desai AA, Humbert M, Nichols WC, Southgate L, Trégouët DA, Trembath RC, Prokopenko I, Gräf S, Morrell NW, Wang D, Lawrie A, Wilkins MR. Rhodes CJ, et al. Among authors: wilkins mr. Am J Respir Crit Care Med. 2020 Aug 15;202(4):586-594. doi: 10.1164/rccm.202003-0510OC. Am J Respir Crit Care Med. 2020. PMID: 32352834 Free PMC article.

2

The natriuretic peptide family: turning hormones into drugs.

Wilkins MR, Nunez DJ, Wharton J. Wilkins MR, et al. J Endocrinol. 1993 Jun;137(3):347-59. doi: 10.1677/joe.0.1370347. J Endocrinol. 1993. PMID: 8371073 Review. No abstract available.

3

NPR-A-Deficient mice show increased susceptibility to hypoxia-induced pulmonary hypertension.

Zhao L, Long L, Morrell NW, Wilkins MR. Zhao L, et al. Among authors: wilkins mr. Circulation. 1999 Feb 9;99(5):605-7. doi: 10.1161/01.cir.99.5.605. Circulation. 1999. PMID: 9950655

4

Vascular remodeling and ET-1 expression in rat strains with different responses to chronic hypoxia.

Aguirre JI, Morrell NW, Long L, Clift P, Upton PD, Polak JM, Wilkins MR. Aguirre JI, et al. Among authors: wilkins mr. Am J Physiol Lung Cell Mol Physiol. 2000 May;278(5):L981-7. doi: 10.1152/ajplung.2000.278.5.L981. Am J Physiol Lung Cell Mol Physiol. 2000. PMID: 10781429 Free article.

5

Genetic and molecular mechanisms of pulmonary hypertension.

Morrell NW, Wilkins MR. Morrell NW, et al. Among authors: wilkins mr. Clin Med (Lond). 2001 Mar-Apr;1(2):138-45. doi: 10.7861/clinmedicine.1-2-138. Clin Med (Lond). 2001. PMID: 11333460 Free PMC article. Review.

6

Characterization of adenylyl cyclase isoforms in rat peripheral pulmonary arteries.

Jourdan KB, Mason NA, Long L, Philips PG, Wilkins MR, Morrell NW. Jourdan KB, et al. Among authors: wilkins mr. Am J Physiol Lung Cell Mol Physiol. 2001 Jun;280(6):L1359-69. doi: 10.1152/ajplung.2001.280.6.L1359. Am J Physiol Lung Cell Mol Physiol. 2001. PMID: 11350817 Free article.

7

Sildenafil inhibits hypoxia-induced pulmonary hypertension.

Zhao L, Mason NA, Morrell NW, Kojonazarov B, Sadykov A, Maripov A, Mirrakhimov MM, Aldashev A, Wilkins MR. Zhao L, et al. Among authors: wilkins mr. Circulation. 2001 Jul 24;104(4):424-8. doi: 10.1161/hc2901.093117. Circulation. 2001. PMID: 11468204 Clinical Trial.

8

Progress in, and future prospects for, the treatment of primary pulmonary hypertension.

Wilkins MR, Wharton J. Wilkins MR, et al. Heart. 2001 Dec;86(6):603-4. doi: 10.1136/heart.86.6.603. Heart. 2001. PMID: 11711446 Free PMC article. No abstract available.

9

Nitric oxide, phosphodiesterase inhibition, and adaptation to hypoxic conditions.

Wilkins MR, Aldashev A, Morrell NW. Wilkins MR, et al. Lancet. 2002 May 4;359(9317):1539-40. doi: 10.1016/s0140-6736(02)08528-8. Lancet. 2002. PMID: 12047961 No abstract available.

10

Developments in therapeutics for pulmonary arterial hypertension.

Wilkins MR, Møller GM, Ren X, Wharton J. Wilkins MR, et al. Minerva Cardioangiol. 2002 Jun;50(3):175-87. Minerva Cardioangiol. 2002. PMID: 12107399 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

568 results

Search Page